The following clinical testing services are being offered through our reference labs to physicians and patients in China:

  • MammaTyper® breast cancer molecular subtyping (under exclusive partnership with BioNtech AG of Germany)
  • EGFR Mutation Analysis (29 mutations in exons 18, 19, 20 and 21)
  • KRAS Mutation Analysis (codons 12 and 13)
  • BRAF Mutation Analysis (V600E)
  • EML4-ALK Fusion Analysis
  • PIK3CA Mutation Analysis
  • PD-L1 IHC Testing
  • Esoteric Clinical Chemistry Tests
  • Esoteric Immunological Tests
  • MTFHR Genotyping for Folic Acid Supplementation
  • N9 Nutrigenetic Testing

Services in development pipeline include:

  • Previstage GCC Colon Cancer Molecular Staging (Parnered with DiagnoCure Inc.)
  • FGFR1 Gene Amplification Detection
  • ROS1 Gene Rearrangement Analysis
  • Analysis of a proprietary marker for TKI sensitivity in a variety of cancers
  • Microsatellite Instability (MSI) Analysis
  • Analysis of proprietary biomarkers for colorectal cancer theranostics
  • IHC Tests on various CDx biomarkers

We seek to add additional reference lab tests for China.  Learn more about the benefits of partnering with Shuwen.